Optometrists should advise their patients that although these medications are conclusively linked to an increased risk of NAION, the overall risk is still extremely low: only about 2.30 per 100,000 people are diagnosed with NAION each year
As mentioned above, DPP-4 inhibitors can increase endogenous GLP-1 levels by suppressing GLP-1 degradation
Check My Eligibility Patient Reviews Real Experiences with Doctor-Guided Care Customers rate Brand 5 Stars for all-inclusive pricing, speed of delivery & product effectiveness
The loss in productivity each year from missed work, disability and early death related to obesity costs employers more than $11 billion each year
As the global prevalence of AD continues to rise, especially among postmenopausal women, dual agonism targeting estrogen and GLP-1 receptors may represent a novel, physiologically informed approach to prevention and intervention